These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A therapy-resistant chronic leg ulcer treated successfully with topical basic fibroblast growth factor.
    Author: Kurokawa I, Hayami J, Kita Y.
    Journal: J Int Med Res; 2003; 31(2):149-51. PubMed ID: 12760319.
    Abstract:
    We report a patient with rheumatoid arthritis who had a chronic leg ulcer with long-standing resistance to therapy. Topical basic fibroblast growth factor (bFGF) at a dose of 30 micrograms/day for 3 months was clinically effective in reducing the ulcer area by promoting angiogenesis, re-epithelization, granulation and scar formation. bFGF may be an effective treatment for therapy-resistant leg ulcers.
    [Abstract] [Full Text] [Related] [New Search]